1. Hypofractionated postoperative stereotactic radiotherapy for large resected brain metastases
- Author
-
C, Evin, Y, Eude, J, Jacob, C, Jenny, R, Bourdais, B, Mathon, C A, Valery, E, Clausse, J M, Simon, P, Maingon, and L, Feuvret
- Subjects
Oncology ,Radiology, Nuclear Medicine and imaging - Abstract
The aim of the present retrospective study was to report outcomes after hypofractionated stereotactic radiotherapy (HSRT) for resected brain metastases (BM).We reviewed results of patients with resected BM treated with postoperative HSRT (3×7.7Gy to the prescription isodose 70%) between May 2013 and June 2020. Local control (LC), distant brain control (DBC), overall survival (OS), leptomeningeal disease relapse (LMDR), and radiation necrosis (RN) occurrence were reported.Twenty-two patients with 23 brain cavities were included. Karnofsky Performance status (KPS) was≥70 in 77.3%. Median preoperative diameter was 37mm [21.0-75.0] and median planning target volume (PTV) was 23 cmHSRT is the most widely used scheme for larger brain cavities after surgery. The optimal dose and scheme remain to be defined as well as the optimal delay between postoperative SRT and surgery. Dose escalation may be necessary, especially in case of subtotal resection.
- Published
- 2023
- Full Text
- View/download PDF